Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-7771
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice ; volume:6 ; number:1 ; day:5 ; month:2 ; year:2018 ; pages:1-7 ; date:12.2018
Biomarker Research ; 6, Heft 1 (5.2.2018), 1-7, 12.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Xie, Vicki
- Contributor
-
Tong, Daochen
Wallington-Beddoe, Craig T.
Bradstock, Ken F.
Bendall, Linda J.
SpringerLink (Online service)
- DOI
-
10.1186/s40364-018-0120-4
- URN
-
urn:nbn:de:1111-201804019176
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xie, Vicki
- Tong, Daochen
- Wallington-Beddoe, Craig T.
- Bradstock, Ken F.
- Bendall, Linda J.
- SpringerLink (Online service)
Other Objects (12)
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia
The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia
IGF-IR determines the fates of BCR/ABL leukemia
The role of proteostasis in BCR-ABL1-positive acute lymphoblastic leukemia
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia
The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia
IGF-IR determines the fates of BCR/ABL leukemia
The role of proteostasis in BCR-ABL1-positive acute lymphoblastic leukemia
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia
The role of ABL/BCR in the leukemogenic potential of BCR/ABL in Philadelphia chromosome positive leukemia
IGF-IR determines the fates of BCR/ABL leukemia
The role of proteostasis in BCR-ABL1-positive acute lymphoblastic leukemia
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms